Radiomedix
RadioMedix is seeking an experienced Radiochemist to lead process development, radioisotope manufacturing, and life-cycle management of GMP products within the Research and Development department. This critical role involves developing methodologies for chemical and radiochemical handling, validating analytical methods, and supporting clinical drug trials. The position includes supervising team members, ensuring regulatory compliance, and utilizing advanced analytical instrumentation for radiopharmaceutical production.
RadioMedix is a clinical-stage radiopharmaceutical oncology company based in Houston, Texas, specializing in the development and commercialization of targeted alpha and beta therapies as well as next-generation diagnostic imaging agents. The company leverages isotopes such as Ac-225, Lu-177, Pb-212, Pb-203, and Ga-68 to treat and diagnose difficult cancers, with capabilities spanning early-stage R&D through commercial-scale GMP manufacturing. RadioMedix also offers CDMO partnerships and advances its own oncology pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Radiomedix.
Radiomedix didn’t post a salary, so this is our estimate from similar listings.